BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 31189541)

  • 1. Derivation and Validation of a Novel Risk Score to Predict Overcorrection of Severe Hyponatremia: The Severe Hyponatremia Overcorrection Risk (SHOR) Score.
    Woodfine JD; Sood MM; MacMillan TE; Cavalcanti RB; van Walraven C
    Clin J Am Soc Nephrol; 2019 Jul; 14(7):975-982. PubMed ID: 31189541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Criteria for Hyponatremic Overcorrection: Systematic Review and Cohort Study of Emergently Ill Patients.
    Woodfine JD; van Walraven C
    J Gen Intern Med; 2020 Jan; 35(1):315-321. PubMed ID: 31452039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors for overcorrection of severe hyponatremia: a post hoc analysis of the SALSA trial.
    Yang H; Yoon S; Kim EJ; Seo JW; Koo JR; Oh YK; Jo YH; Kim S; Baek SH
    Kidney Res Clin Pract; 2022 May; 41(3):298-309. PubMed ID: 35286796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A low initial serum sodium level is associated with an increased risk of overcorrection in patients with chronic profound hyponatremia: a retrospective cohort analysis.
    Aratani S; Hara M; Nagahama M; Taki F; Futatsuyama M; Tsuruoka S; Komatsu Y
    BMC Nephrol; 2017 Oct; 18(1):316. PubMed ID: 29047375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence and risk factors of overcorrection in patients presenting with severe hyponatremia to the emergency department.
    Sumi H; Imai N; Shibagaki Y
    Clin Exp Nephrol; 2022 Nov; 26(11):1086-1091. PubMed ID: 35870090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patients presenting with severe hypotonic hyponatremia: etiological factors, assessment, and outcomes.
    Vu T; Wong R; Hamblin PS; Zajac J; Grossmann M
    Hosp Pract (1995); 2009 Dec; 37(1):128-36. PubMed ID: 20877181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of desmopressin acetate in severe hyponatremia in the intensive care unit.
    Rafat C; Schortgen F; Gaudry S; Bertrand F; Miguel-Montanes R; Labbé V; Ricard JD; Hajage D; Dreyfuss D
    Clin J Am Soc Nephrol; 2014 Feb; 9(2):229-37. PubMed ID: 24262506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early Relowering of Serum Sodium Concentration Overcomes Disturbances in Consciousness during Hyponatremia Overcorrection and Prevents Osmotic Demyelination Syndrome.
    Ochiai H; Uenishi E
    Intern Med; 2018; 57(16):2353-2357. PubMed ID: 30111674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preventing overcorrection of hyponatraemia with desmopressin.
    Tomlin SC; Williams R; Riley S
    BMJ Case Rep; 2011 Nov; 2011():. PubMed ID: 22674100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes in Severe Hyponatremia Treated With and Without Desmopressin.
    MacMillan TE; Cavalcanti RB
    Am J Med; 2018 Mar; 131(3):317.e1-317.e10. PubMed ID: 29061503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Osmotic Demyelination Syndrome following Correction of Hyponatremia by ≤10 mEq/L per Day.
    Tandukar S; Sterns RH; Rondon-Berrios H
    Kidney360; 2021 Sep; 2(9):1415-1423. PubMed ID: 35373113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DDAVP is effective in preventing and reversing inadvertent overcorrection of hyponatremia.
    Perianayagam A; Sterns RH; Silver SM; Grieff M; Mayo R; Hix J; Kouides R
    Clin J Am Soc Nephrol; 2008 Mar; 3(2):331-6. PubMed ID: 18235152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors for sodium overcorrection in non-hypovolemic hyponatremia patients treated with tolvaptan.
    Kim Y; Lee N; Lee KE; Gwak HS
    Eur J Clin Pharmacol; 2020 May; 76(5):723-729. PubMed ID: 32055900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of intranasal desmopressin therapy with overcorrection of severe hyponatremia: A retrospective, propensity score-based, single-center cohort study.
    Jingushi N; Tsuzuki S; Fujii K; Uenishi N; Iwata M; Terasawa T
    J Crit Care; 2021 Aug; 64():53-61. PubMed ID: 33794467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Osmotic demyelination syndrome following correction of hyponatremia: association with hypokalemia.
    Lohr JW
    Am J Med; 1994 May; 96(5):408-13. PubMed ID: 8192171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Managing hyponatraemia secondary to primary polydipsia: beware too rapid correction of hyponatraemia.
    Boehm E; Kumar S; Nankervis A; Colman P
    Intern Med J; 2017 Aug; 47(8):956-959. PubMed ID: 28782208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk Factors and Outcomes of Rapid Correction of Severe Hyponatremia.
    George JC; Zafar W; Bucaloiu ID; Chang AR
    Clin J Am Soc Nephrol; 2018 Jul; 13(7):984-992. PubMed ID: 29871886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of Serum Sodium Correction Rates for Management of Hyponatremia in Hospitalized Patients.
    Pham CT; Kassab HS; Johnston JP
    Ann Pharmacother; 2022 Feb; 56(2):131-138. PubMed ID: 34027713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypertonic saline and desmopressin: a simple strategy for safe correction of severe hyponatremia.
    Sood L; Sterns RH; Hix JK; Silver SM; Chen L
    Am J Kidney Dis; 2013 Apr; 61(4):571-8. PubMed ID: 23266328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of hyponatremia.
    Sterns RH; Hix JK; Silver S
    Curr Opin Nephrol Hypertens; 2010 Sep; 19(5):493-8. PubMed ID: 20539224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.